In an era where innovation is at the forefront of healthcare, one fundamental aspect remains overlooked: accessibility and ...

Contract research organizations are reporting better-than-expected second-quarter profit, a sign that Wall Street analysts ...

Global healthcare stocks have not been this cheap in decades and fund inflows into the sector are picking up, yet the shares ...

Pharmaceutical company Apnimed says it's getting positive results from the clinical trials for an oral pill that could treat ...

The startup is using elements of gene and cell therapy to create medicines that could be useful against an array of ...

Dispatch Bio is developing a universal immunotherapy by trying to install a synthetic protein — called the “flare” antigen — ...

The announcement by AstroZeneca follows a growing trend of companies pledging to invest in pharmaceutical manufacturing on American soil in pursuit of appeasing President Donald Trump as he threatens ...

Markets reflect a widespread belief that the US president always chickens out on trade measures. AstraZeneca’s plan to invest ...

The biotech is planning to expand antisense oligonucleotide capabilities and infrastructure on campuses that already produce ...